These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2643208)

  • 21. [HTLV examination of Norwegian blood donors].
    Samdal HH; Skaug K; Stigum H; Hervig T; Kjeldsen-Kragh J; Skar AG
    Tidsskr Nor Laegeforen; 1999 Jan; 119(2):206-8. PubMed ID: 10081351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental transmission of HTLV-I into C3H/HeJ mice.
    Ohsugi T; Chinami M; Yuge K; Hachiya N; Shingu M
    Kurume Med J; 1993; 40(2):89-91. PubMed ID: 8231068
    [No Abstract]   [Full Text] [Related]  

  • 23. Declining trends in HTLV-I prevalence among blood donors in Japan.
    Yamaguchi K
    Intern Med; 2001 Jan; 40(1):1-2. PubMed ID: 11201361
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT; Williams AE; Fang CT; Notari EP; Poiesz BJ; Ehrlich GD
    Transfusion; 1993 Jul; 33(7):585-90. PubMed ID: 8333022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HTLV-I infections in French Guiana as monitored by western-blot, dot-blot and PCR techniques.
    Moynet D; Berteau F; Astier-Gin T; Legrand E; Sainte-Foie S; Joly F; Moreau JP; Guillemain B
    Leukemia; 1992; 6 Suppl 3():106S-109S. PubMed ID: 1602804
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk behaviour and HTLV-1 seropositivity in injecting drug users.
    Rezza G; Lazzarin A; Uberti-Foppa C; Tumbarello M; Menniti-Ippolito F; Pezzotti P; Titti F; Verani P
    Br J Addict; 1990 May; 85(5):686-7. PubMed ID: 2354287
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibodies to human T-cell leukemia virus type 1 in patients with malignancies in the Gizan area of Saudi Arabia.
    Arya SC; Ashraf SJ; Pathak VP; Parande CK
    J Commun Dis; 1990 Dec; 22(4):281-2. PubMed ID: 2098436
    [No Abstract]   [Full Text] [Related]  

  • 30. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of HTLV-I viral antibodies in donor blood samples].
    Iakovleva LS; Seniuta NB; Stepina VN; Gurtsevich VE; Buachidze LN
    Vopr Virusol; 1989; 34(2):174-6. PubMed ID: 2669334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV, UK: 2002-2006.
    Davison KL; Dow B; Barbara JA; Hewitt PE; Eglin R
    Transfus Med; 2009 Feb; 19(1):24-34. PubMed ID: 19302452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Licensure of screening tests for antibody to human T-lymphotropic virus type I.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Dec; 37(48):736-40, 745-7. PubMed ID: 3143058
    [No Abstract]   [Full Text] [Related]  

  • 35. Leads from the MMWR. Licensure of screening tests for antibody to human T-lymphotropic virus type I.
    JAMA; 1989 Jan; 261(4):513, 518-20, 525. PubMed ID: 2642562
    [No Abstract]   [Full Text] [Related]  

  • 36. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil.
    Ferreira Júnior OC; Vaz RS; Carvalho MB; Guerra C; Fabron AL; Rosemblit J; Hamerschlak N
    Transfusion; 1995 Mar; 35(3):258-63. PubMed ID: 7878720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
    Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
    J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTLV-I infection in human disease.
    Spalton DJ; Nicholson F
    Br J Ophthalmol; 1991 Mar; 75(3):174-5. PubMed ID: 2012786
    [No Abstract]   [Full Text] [Related]  

  • 39. [Seroprevalence rate of HTLV-I in pregnant women in Osaka Prefecture].
    Kamiura S; Ohashi K; Azuma C; Saji F; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1855-8. PubMed ID: 2592810
    [No Abstract]   [Full Text] [Related]  

  • 40. HTLV-I antibody screening in donated blood and thalassemic patients.
    Chiewsilp P; Iamsilp W; Hathirat P
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():103-5. PubMed ID: 7822977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.